Jeff Milush serves as the Director of Cytometry at ArsenalBio, where he plays a pivotal role in advancing the company's innovative gene-modified cellular drug products. With a robust background in biotechnology startups, Jeff excels in leading translational science and clinical biomarker strategy, ensuring that ArsenalBio...
Jeff Milush serves as the Director of Cytometry at ArsenalBio, where he plays a pivotal role in advancing the company's innovative gene-modified cellular drug products. With a robust background in biotechnology startups, Jeff excels in leading translational science and clinical biomarker strategy, ensuring that ArsenalBio remains at the forefront of cutting-edge therapies. His expertise encompasses a wide range of scientific disciplines, including cell biology, virology, and the intricacies of flow cytometry, which are critical for the development and analysis of cellular therapies.
In his current role, Jeff is responsible for building and managing a high-performing team of scientists and research associates dedicated to flow cytometry across various platforms, including discovery, automation, manufacturing, and clinical applications. This involves not only overseeing the technical aspects of cytometry but also integrating biomarker and translational research plans into the broader framework of ArsenalBio's clinical studies. His contributions are instrumental in the planning and execution of clinical trials, where he reviews clinical protocols and collaborates with medical affairs to ensure alignment with regulatory standards and scientific rigor.
Jeff's commitment to advancing the field of biotechnology is evident in his hands-on approach to project management and his proficiency in techniques such as qPCR and spectral cytometry. By leveraging his extensive experience and deep understanding of animal models and cell culture, he drives the development of innovative solutions that address unmet medical needs. As a key member of the translational science team, Jeff is dedicated to translating scientific discoveries into viable therapeutic options, ultimately enhancing patient outcomes and contributing to the evolution of precision medicine.
